These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20164732)

  • 1. Contraceptive for obese women: considerations.
    Kelsey B
    Nurse Pract; 2010 Mar; 35(3):24-31; quiz 31-2. PubMed ID: 20164732
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peroral hormonal contraception and risk of venous thromboembolism].
    Ludka O; Spinar J; Musil V; Pozdísek Z
    Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contraception: methods, contraindications, surveillance].
    Lopes P; Mensier A
    Rev Prat; 2000 Feb; 50(4):451-60. PubMed ID: 10748681
    [No Abstract]   [Full Text] [Related]  

  • 4. Venous thromboembolism in women taking hormonal contraceptives.
    Blanco-Molina A; Monreal M
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):211-5. PubMed ID: 20136607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral contraceptive use on the incidence of impaired glucose tolerance and diabetes mellitus.
    Harvengt C
    Diabete Metab; 1992; 18(2):71-7. PubMed ID: 1511755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evidence-based approach to hormonal contraception and headaches.
    Harris M; Kaneshiro B
    Contraception; 2009 Nov; 80(5):417-21. PubMed ID: 19835714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined hormonal contraception and the risk of venous thromboembolism: a guideline.
    ;
    Fertil Steril; 2017 Jan; 107(1):43-51. PubMed ID: 27793376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
    Plu-Bureau G; Horellou MH; Gompel A; Conard J
    Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Contraceptive Methods for Obese and Overweight Women.
    Lotke PS; Kaneshiro B
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):647-57. PubMed ID: 26598306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined oral contraceptive pill -- recent developments, risks and benefits.
    Dragoman MV
    Best Pract Res Clin Obstet Gynaecol; 2014 Aug; 28(6):825-34. PubMed ID: 25028259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1998; 877():i-vii, 1-89. PubMed ID: 9615606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Weight gain due to hormonal contraception: myth or truth?].
    Häni D; Imthurn B; Merki-Feld GS
    Gynakol Geburtshilfliche Rundsch; 2009; 49(2):87-93. PubMed ID: 19346753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
    Urdinola J
    Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral contraceptives and venous thromboembolic events.
    Shulman LP; Goldzieher JW; Minkin MJ; Sulak PJ; Thorneycroft I
    J Reprod Med; 2003 Apr; 48(4):306-7. PubMed ID: 12747000
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diffuse symptoms in young women may indicate venous thromboembolism. Important to ask about the use of combined hormonal contraception].
    Milsom I; von Sydow H; Thörn AB; Björkelund C; Odlind V
    Lakartidningen; 2012 Sep 19-26; 109(38):1680-2. PubMed ID: 23094400
    [No Abstract]   [Full Text] [Related]  

  • 16. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):878-83. PubMed ID: 21734635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profile and recurrence rate in women with venous thromboembolism during combined hormonal contraceptive use: a prospective cohort study.
    van Vlijmen EF; Mäkelburg AB; Knol HM; Tichelaar VI; Kluin-Nelemans HC; Veeger NJ; Meijer K
    Br J Haematol; 2016 Feb; 172(4):636-8. PubMed ID: 26105591
    [No Abstract]   [Full Text] [Related]  

  • 18. FPIN's clinical inquiries. Cardiovascular risk of combined oral contraceptive use.
    Fehr AD; Mounsey A; Yates JE; Flake D
    Am Fam Physician; 2012 Dec; 86(12):1-2. PubMed ID: 23316994
    [No Abstract]   [Full Text] [Related]  

  • 19. [Which contraception for women with increased risk of venous thromboembolism?].
    Julen O; Dubuisson JB; Lourenço AG
    Rev Med Suisse; 2011 Feb; 7(281):351-4, 356. PubMed ID: 21416714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contraception for women: an evidence based overview.
    Amy JJ; Tripathi V
    BMJ; 2009 Aug; 339():b2895. PubMed ID: 19666684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.